Two Investigational Treatments for ALS Show Glimmer of Hope
(MedPage Today) — The first four treatments in a platform trial for amyotrophic lateral sclerosis (ALS) failed to reach key endpoints in phase II studies, but two treatments — pridopidine and CNM-Au8 — showed glimmers of hope.
All treatments…
